A tool by Firecrawl · uses 6 tools · Healthcare

Drug shortage impact assessment

Use when a hospital pharmacy director or supply chain lead learns a drug is short and needs to plan. Reads the FDA shortage entry, finds alternative labelers and presentations, checks recalls at the affected manufacturer, compares the EU shortage picture and lists clinical trials that depend on the drug.

Open in ChatGPT Open in Claude

Save a copy for your team

Tools it calls

Each tool's price and track record across every agent today. Empty means the call worked and found nothing.

ToolPriceMedianSuccessEmpty

FDADrug shortagesPrice5 creditsMedian–Success–Empty–
FDADrug recallsPrice5 creditsMedian505 msSuccess92%Empty87%
FDADrug ndcPrice5 creditsMedian–Success–Empty–
FDADrug labelsPrice5 creditsMedian–Success–Empty–
European Medicines AgencyShortagesPrice5 creditsMedian–Success–Empty–
ClinicalTrials.govSearchPrice5 creditsMedian88 msSuccess100%Empty30.3%

Instructions

What your agent follows when it runs this tool. Paste them into any assistant connected to Firecrawl.

# Drug shortage impact assessment

For one generic drug. The FDA entry alone does not say how long it will last or what to switch to; recalls, other labelers and the EU picture do.

## 1. The shortage itself

1. Search @[FDA · Drug shortages](alexandria:fda-gov/records/drug_shortages) with generic_name. Keep status, affected presentations, the **company** names, therapeutic category and posting and update dates.

## 2. Why, and what else exists

2. Search @[FDA · Drug recalls](alexandria:fda-gov/records/drug_recalls) with each company from step 1 as recalling_firm over the last 18 months: a quality recall often explains a shortage and its likely length.
3. Search @[FDA · NDC directory](alexandria:fda-gov/records/drug_ndc) with the same generic_name: list every other **labeler**, dosage form, route and package that could substitute.
4. Check the label of the leading substitute with @[FDA · Drug labels](alexandria:fda-gov/records/drug_labels) for dosing or indication differences.

## 3. Is it global

5. Search @[EMA · EMA shortages](alexandria:ema-europa-eu/records/shortages) with the INN: a parallel EU shortage points to an upstream active-ingredient problem rather than one plant.

## 4. Who else depends on it

6. Search @[ClinicalTrials.gov · Trial search](alexandria:clinicaltrials-gov/clinical-trials/search) with the drug as intervention and status recruiting: trials at your sites may need protocol deviations.

## Write the assessment

- **Status:** what is short, since when, which presentations, likely cause.
- **Substitutes:** table of labeler, form, NDC and any label difference.
- **Global signal:** EU status and what it implies for duration.
- **Actions:** conservation, substitution and trial-team notices, most urgent first.
- **Sources:** cite each record id, NDC and NCT number. Say what could not be found.

All Firecrawl tools